Arlene Gayle, MD
Hematology · Orlando, FLNPI 1831206101
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,017 of the $13,886 with a category attached, or 86.5%. Pfizer accounts for 68.0% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $9,832, more than ten times the $114 reported in 2021.
Across 69 payments — averaging $201.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$9K
- CTI Biopharma Corp.$3K
- Bristol Myers Squibb$313
- Gilead$277
- Johnson & Johnson$262
- Novartis$109
- plus $705 from 14 others
Across 9 payments — averaging $6637.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$31K
- Genentech, Inc.$27K
- Janssen Research & Development, LLC$906
What the payments were for
- Consulting fees$12,01787%
- Speaking & faculty fees$400%
- Food & beverage$1,82913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 7 | $9,442 |
| CTI Biopharma Corp. | 1 | $2,777 |
| Bristol Myers Squibb | 17 | $313 |
| Gilead | 4 | $277 |
| Johnson & Johnson | 2 | $262 |
| Novartis | 6 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Sanofi-aventis U.S. LLC | 4 | $84 |
| Janssen Research & Development, LLC | 2 | $80 |
| Seagen Inc. | 4 | $72 |
| Adaptive Biotechnologies Corporation | 3 | $61 |
| AbbVie | 2 | $54 |
| Beigene USA, Inc. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $37 |
| Janssen Scientific Affairs, LLC | 1 | $34 |
| Karyopharm Therapeutics Inc. | 2 | $33 |
| Genmab U.S., Inc. | 1 | $30 |
| Amgen | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Rigel Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,886 in reported general payments places this provider in the 70th percentile of 79 hematology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Orlando
- Juan VarelaOrlando$131K
- Philip PancariOrlando$70K
- Kayla DesuzaOrlando$7K
- Daniel AnscherOrlando$2K
- Ayman MukhtarOrlando$761
- Phillip MannoOrlando$153
- Javier Pinilla-IbarzTampa$1.6M
- Rami KomrokjiTampa$855K
- Ahmed ZakariAltamonte Springs$383K
- Alex Mejia GarciaVero Beach$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.